Shiraz University of Medical Sciences
147
2
2
117
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.7%
1 terminated/withdrawn out of 147 trials
99.2%
+12.6% vs industry average
20%
29 trials in Phase 3/4
3%
3 of 117 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (147)
Comparing Bisoprolol and Valsartan-Amlodipine for Hypertension
Role: lead
Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients
Role: lead
Effect of Probiotic Supplement on Improvement of Depressive Symptoms in Patients With Substance-Induced Depressive Disorder
Role: lead
CTFFR and Prediction of Non-Significant CAD Lesions
Role: lead
Ticagrelore Alone Post PCI
Role: lead
MSCs for Prevention of MI-induced HF
Role: lead
Quality of Care and Welfare Services for Disabled Middle Older Adults in Iran Lebanon
Role: lead
Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy
Role: lead
MACE in Different Drug-Eluting Stents
Role: lead
Pain Severity in Flapless Dental Implant Placement Using Laser
Role: lead
The Predictive Value of Coronary Artery Calcium Score
Role: lead
Insulin Resistance Indices and Coronary Artery Disease
Role: lead
The Effects of Action Observation Therapy (AOT) on Balance and Gait in Patients With Multiple Sclerosis.
Role: lead
Rivaroxaban Post Coronary Bypass Surgery
Role: lead
Ticagrelor vs. Clopidogrel in Post PCI Patients
Role: lead
Covid-19 Infection and Long-term Cardiovascular Symptoms
Role: lead
Effect of Covid-19 on Hypertension
Role: lead
Probiotic in Dry Eye Syndromes
Role: lead
Efficacy of Education Via Phone-based Text Messaging (SMS) on Patients With Uncontrolled Hypertension
Role: lead
Is Sheep Ghee Cardioprotective?
Role: lead